DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of meeting of Analyst(s) / Investor(s)21-08-2019
21-08-2019
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of meeting of Analyst(s) / Investor(s)21-08-2019
DIVI'S LABORATORIES LTD. - 532488 - Compliance Of Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the above subject, we wish to inform you that, the Board of Directors at its meeting held on 10th August, 2019 revised the contact details of the officials for the purpose of determining materiality of an event or information and to make disclosures to Stock Exchanges on which the Company's Securities are traded. The revised details are enclosed herewith.20-08-2019
Divis Laboratories Ltd - 532488 - Revised Press Release On The Financials Of The Company For The Quarter Ended 30Th June 2019 -Reg
Further to our submission dated 10th August 2019, we would like to inform that inadvertently in the Press Release on the financial results for the quarter ended 30th June 2019, the US-FDA inspection period was mentioned incorrectly. We herewith submit the revised Press Release after rectifying the error. This is for your information and records.10-08-2019
Divis Laboratories Ltd - 532488 - Un-Audited Financial Results For The First Quarter Ended 30Th June, 2019 And Limited Review Report -Reg
Further to our intimation dated 01st August 2019, we would like to inform that the Board of Directors of the Company at its meeting held on Saturday, 10th August 2019 has approved the Un-audited Financial Results for the first quarter ended 30th June 2019. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following: 1. Un-audited Standalone Financial Results for the quarter ended 30th June 2019 along with Limited Review Report of the Statutory Auditors. 2. Un-audited Consolidated Financial Results for the quarter ended 30th June 2019 along with Limited Review Report of the Statutory Auditors. 3. Press Release on the Financial Results of the Company. The Board meeting commenced at 11:00 Hrs and concluded at 14.20 Hrs This is for your information and records.10-08-2019
DIVI'S LABORATORIES LTD. - 532488 - Submission Of Information Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the Company in their meeting held on 10th August 2019 appointed Mr. M. Satish Choudhury as Company Secretary and Compliance Officer of the Company with immediate effect. Brief profile of Mr. M. Satish Choudhury is as follows: Mr. M. Satish Choudhury is B.Sc., LL.B. and a qualified Company Secretary. He has over 7+ years of post-qualification experience which includes experience in working with various listed companies.10-08-2019
Divis Laboratories Ltd - 532488 - Board Meeting Intimation for Considering And Approving Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30 June, 2019
DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2019 ,inter alia, to consider and approve Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, 10 August, 2019, inter-alia, to consider and approve standalone and consolidated un-audited financial results for the quarter ended 30 June, 2019. As intimated earlier, the Trading Window for dealing in securities of the Company has been closed from 01 July, 2019 till 48 hours after the declaration of financial results as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.01-08-2019
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sub: Newspaper Publication - Notice of 29th Annual General Meeting, Remote E-Voting and Book Closure Information -reg Pursuant to Regulation 47 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements published on 27 July, 2019 in the newspapers - Financial Express (English Daily) and Andhra Prabha (Telugu Daily), informing: i. Details of 29th Annual General Meeting (AGM) of the Company and despatch of Annual Report 2018-19 along with Notice of AGM; ii. Details of remote e-voting; and iii. Book Closure Information. The information is also available in the website of the Company www.divislabs.com. This is for your information and records.27-07-2019
DIVI'S LABORATORIES LTD. - 532488 - Notice Of 29Th Annual General Meeting
We hereby inform that 29th Annual General Meeting (AGM) of the members of the Company will be held on Friday, 23 August, 2019 at 10.00 A.M. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500032, Telangana, India.25-07-2019
Divis Laboratories Ltd - 532488 - Intimation Of Book Closure For The Purpose Of The Annual General Meeting Of The Company And Payment Of Dividend, If Declared At The Ensuing Annual General Meeting.
We hereby inform that 29th Annual General Meeting (AGM) of the members of the Company will be held on Friday, 23 August, 2019 at 10.00 A.M. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500032, Telangana, India. Pursuant to Regulation 42 of the SEBI Listing Regulations, the Register of Member and Share Transfer Books of the Company will remain closed from 17 August, 2019 to 23 August, 2019 (both days inclusive) for taking record of the Members of the Company for the purpose of the Annual General Meeting of the Company and payment of dividend, if declared at the ensuing Annual General Meeting. We further wish to inform you that the Board of Directors at its meeting held on 25 May, 2019 has recommended a dividend of Rs. 16/- per equity share of Rs. 2/- face value i.e., 800% for the year ended 31 March, 2019 and the dividend, if declared at the Annual General Meeting, will be credited / dispatched on or before 06 September, 2019. The Annual Report containing the AGM Notice is also uploaded on the Company''s website www.divislabs.com.25-07-2019